From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
Morgan Stanley reaffirms its Overweight rating on Nvidia with a $250 price target, citing the company's systemic advantage through its Vera Rubin platform and robust hyperscaler spending, despite acknowledging competitive and demand risks.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
In a significant policy shift, Chinese authorities have reportedly cleared the AI startup DeepSeek to purchase Nvidia's advanced H200 processors, potentially easing a major hardware bottleneck for its competitive large language model.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
The drive-thru coffee chain 7 Brew debuts a monthly rotating menu of featured beverages, starting with five options for February including a new Chocolate Dipped Strawberry Cold Brew, as it leverages its strong rewards membership to boost visit frequency.
Mosaic Company's shares have surged over 16% in the past month, reigniting debate among investors. A deep dive into valuation metrics reveals a stark contradiction: while a discounted cash flow model flags the stock as overvalued, its rock-bottom P/E ratio suggests significant upside potential. We break down the numbers and what they mean for long-term investors.
As SpaceX targets a record-shattering IPO for mid-2026, reports indicate Elon Musk is exploring a potential merger with either Tesla or his AI startup, xAI. The move could create a unified tech and industrial behemoth but faces significant regulatory and operational hurdles.
The iconic California-born chain Peet's Coffee is closing 27 locations, including outlets in Manhattan Beach and Redondo Beach, as it navigates post-acquisition restructuring and a challenging market for mid-size coffee retailers.
The potential nomination of former Fed Governor Kevin Warsh has sent ripples through financial markets, spotlighting his complex history with cryptocurrency—from early-stage investor to critic of Bitcoin as money, and now a proponent of a U.S. digital dollar.
Apple's Q1 earnings showcased blockbuster iPhone revenue of $85.3 billion, yet investor caution prevails amid persistent supply chain constraints and mounting cost pressures that threaten near-term profitability.
The U.S. dollar rallied sharply while gold and silver prices plunged following President Trump's nomination of former Fed Governor Kevin Warsh as the next Federal Reserve Chair. The move, coupled with stronger-than-expected U.S. economic data, signals a potential hawkish shift in monetary policy.
With rising demand, grid investments, and volatile fuel costs, electricity prices are outpacing wage growth, squeezing not just low-income but now middle-class households. Policy interventions face long lead times, leaving little hope for near-term bill relief.
XPO's dual recognition of driver safety excellence coincides with significant institutional options activity targeting 2026, setting the stage for a pivotal period as the company navigates leadership change and high expectations for its core LTL business.
Waste Management (NYSE:WM) announced a significant 14.5% dividend hike and a new $3 billion share buyback program, signaling confidence in its cash flow strength despite competitive pressures. The move comes as the waste giant continues to invest in renewable natural gas and automation to drive future growth.
Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.
Insulet (PODD) shares have faced significant pressure in recent months, diverging from the company's underlying business performance. This analysis delves into whether the current price weakness presents a buying opportunity for the Omnipod maker or reflects deeper market concerns about its premium valuation and growth sustainability.
The FDA has cleared Intuitive Surgical's da Vinci 5 robotic system for select complex cardiac procedures, a move that could reshape the landscape of minimally invasive heart surgery and open a significant new market for the industry leader.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
The commencement of sea trials for the nuclear-powered aircraft carrier USS John F. Kennedy coincides with the 140th anniversary of its builder, Newport News Shipbuilding, underscoring Huntington Ingalls Industries' entrenched role in U.S. naval defense and its long-term investment profile.
